 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 91 - 100 of 2187:
AMA Backs FDA Pre-Screening of Direct-to-Consumer TV Drug Ads
The American Medical Association, testifying before Congress, has endorsed the proposal that the FDA should review and approve all direct-to-consumer ...
AMAG imaging agent gets FDA fast-track designation
AMAG Pharmaceuticals Inc. has gotten fast-track designation from federal regulators for its new MRI diagnostic imaging agent. The Cambridge, Mass.-bas...
America needs a strong FDA
AS PRESIDENT-ELECT Barack Obama focuses on selecting leaders for his administration, a top priority should be to rebuild the Food and Drug Administrat...
Amgen asks FDA to approve osteoporosis drug
Biotechnology company Amgen Inc. said Friday it asked the Food and Drug Administration for approval of its osteoporosis drug candidate denosumab. T...
Amgen Gets Its FDA Response
Amgen (Nasdaq: AMGN) investors can finally breathe a little sigh of relief after the biopharma giant announced on Friday that the Food and Drug Admin...
Amgen says FDA accepts bone loss drug application
Amgen Inc. said Wednesday the Food and Drug Administration accepted its application for the bone loss drug candidate denosumab, and the company expect...
Amgen Told to Reword Drug Label
The Food and Drug Administration has ordered Amgen to change the labels for its flagship anemia drugs in a way that could further restrict their use i...
Amneal Receives FDA Approval for Bethanechol Chloride Tablets, USP Using New Expedited..
Amneal Pharmaceuticals is pleasedto announce that it received US FDA approval to manufacture BethanecholChloride Tablets, USP in strengths of 5mg, 10m...
An Alternative To Botox gets FDA's Approval
A new wrinkle-remover, Dysport, for cosmetic and therapeutic use has been sanctioned by the Food and Drug Administration. Like Botox, it's an injectab...
An Approval for Johnson & Johnson rheumatoid arthritis drug golimumab by FDA
A rheumatoid arthritis drug designed to be injected less often than its top-selling product, Remicade has won the approval of Johnson & Johnson. The d... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |